Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 283,703 | 214,161 | 147,285 | 102,049 | 99,086 |
| Gross Profit | 283,703 | 214,161 | 147,285 | 102,049 | 99,086 |
| Operating Expenses | 359,465 | 261,891 | 198,951 | 170,973 | 170,186 |
| Operating Income | -75,762 | -47,730 | -51,666 | -68,924 | -71,100 |
| Interest Expense | 36,732 | 22,209 | 19,355 | 21,152 | 16,732 |
| Other Income | 24,588 | 15,548 | 4,463 | 15,489 | 3,042 |
| Pre-tax Income | -87,906 | -54,391 | -66,558 | -74,587 | -84,790 |
| Income Tax | 372 | -15,407 | -5,914 | -9,109 | 11 |
| Net Income Continuous | -88,278 | -38,984 | -60,644 | -65,478 | -84,801 |
| Net Income | $-88,278 | $-38,984 | $-60,644 | $-65,478 | $-84,801 |
| EPS Basic Total Ops | -0.74 | -0.33 | -0.55 | -0.65 | -0.85 |
| EPS Basic Continuous Ops | -0.74 | -0.33 | -0.55 | -0.65 | -0.85 |
| EPS Diluted Total Ops | -0.74 | -0.33 | -0.55 | -0.65 | -0.85 |
| EPS Diluted Continuous Ops | -0.74 | -0.33 | -0.55 | -0.65 | -0.85 |
| EBITDA(a) | $-27,839 | $-14,660 | $-22,986 | $-38,417 | $-41,974 |